A NOVEL CLASS OF ANTAGONISTS FOR ROBUST INHIBITION OF MUTANT ESTROGEN RECEPTOR ACTION IN ENDOCRINE-RESISTANT METASTATIC BREAST CANCER

Sloan-Kettering Institute For Cancer Research

Investigators